Fully closed cell sorter for immune cell therapy manufacturing

By analyzing patients treated with adoptive immune cell therapies, various immune cell phenotypes have been found in the starting and infused materials as determinants of sustained remission. The isolation of these specific phenotypes for clinical use requires current Good Manufacturing Practice (cG...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Masahiro, Tashiro, Shinji, Ito, Tatsumi, Takahashi, Kazuya, Hashimoto, Gakuji, Kajihara, Junji, Miyahara, Yoshihiro, Shiku, Hiroshi, Katsumoto, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457513/
https://www.ncbi.nlm.nih.gov/pubmed/37637381
http://dx.doi.org/10.1016/j.omtm.2023.07.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457513/
https://www.ncbi.nlm.nih.gov/pubmed/37637381
http://dx.doi.org/10.1016/j.omtm.2023.07.012

Ejemplares similares